| V5811 - Encounter for antineoplastic chemotherapy - as a primary diagnosis code | V5811 - Encounter for antineoplastic chemotherapy - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.25 | |
| Readmission Rate (%) | 62.29 | |
| Unplanned Readmission Rate (%) | 12.71 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 34,232 | ||||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 33,261 | ||||
| DRG Share of Total Hospitalizations | 0.15 | ||||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 63.46 | ||||
| Avg LOS at DRG | 3.88 | ||||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 3.87 | ||||
| Readmission Rate at DRG | 66.5 | ||||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 66.5 | ||||
| Unplanned Readmission Rate at DRG | 11.1 | ||||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 11.07 | ||||
| Total Medicare payments at DRG | $291,405,055 | ||||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $280,678,322 | ||||
| Total Medicare payment per Day at DRG | $2,196 | ||||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,180 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,513 | ||||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $8,439 | ||||
| Total Medicare Charges at DRG | $1,360,927,734 | ||||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $1,308,332,390 | ||||
| Avg Charges at DRG | $39,756 | ||||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $39,335 | ||||
| Mortality Rate at DRG | 0.08 | ||||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 0.08 | ||||
| SNF Discharge Rate at DRG | 4.73 | ||||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 4.78 | ||||
| Home Discharge Rate at DRG | 82.24 | ||||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 82.15 |
| DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,355 | ||||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 1,339 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 2.55 | ||||
| Avg LOS at DRG | 3.15 | ||||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 3.16 | ||||
| Readmission Rate at DRG | 61.24 | ||||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 61.38 | ||||
| Unplanned Readmission Rate at DRG | 8.65 | ||||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 8.68 | ||||
| Total Medicare payments at DRG | $9,126,653 | ||||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $9,027,539 | ||||
| Total Medicare payment per Day at DRG | $2,135 | ||||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,131 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,736 | ||||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $6,742 | ||||
| Total Medicare Charges at DRG | $38,776,328 | ||||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $38,136,669 | ||||
| Avg Charges at DRG | $28,617 | ||||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $28,481 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 3.03 | ||||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 3.06 | ||||
| Home Discharge Rate at DRG | 87.97 | ||||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 87.98 |
| DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 999: UNGROUPABLE | DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | |
|---|---|---|---|
| Total Hospitalizations at DRG | 1,976 | ||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 31 | ||
| DRG Share of Total Hospitalizations | 0.01 | ||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 0.06 | ||
| Avg LOS at DRG | 27.11 | ||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 39.68 | ||
| Readmission Rate at DRG | 29.85 | ||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 38.71 | ||
| Unplanned Readmission Rate at DRG | 9.12 | ||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||
| Total Medicare payments at DRG | $187,831,727 | ||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $3,095,886 | ||
| Total Medicare payment per Day at DRG | $3,506 | ||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,517 | ||
| Total Medicare payment per Hospitalization at DRG | $95,057 | ||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $99,867 | ||
| Total Medicare Charges at DRG | $770,740,255 | ||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $14,379,382 | ||
| Avg Charges at DRG | $390,051 | ||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $463,851 | ||
| Mortality Rate at DRG | 4.76 | ||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||
| SNF Discharge Rate at DRG | 1.62 | ||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||
| Home Discharge Rate at DRG | 66.4 | ||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 77.42 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2013 to Dec 2014 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 2,000 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 572 |
| MOFFITT CANCER CENTER | 12902 MAGNOLIA DR | TAMPA | FL | 33612 | 513 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2013 to Dec 2014 ) |
|---|---|---|---|---|---|
| Dr. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 223 |
| Dr. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 184 |
| Dr. ARLENE O. SIEFKER-RADTKE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 162 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2013 to Dec 2014 ) |
|---|---|---|---|---|---|
| Dr. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 231 |
| Dr. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 187 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 132 |
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 34,232 | ||||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 33,744 | ||||
| DRG Share of Total Hospitalizations | 0.15 | ||||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 59.37 | ||||
| Avg LOS at DRG | 3.88 | ||||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 3.87 | ||||
| Readmission Rate at DRG | 66.5 | ||||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 66.6 | ||||
| Unplanned Readmission Rate at DRG | 11.1 | ||||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 11.13 | ||||
| Total Medicare payments at DRG | $291,405,055 | ||||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $286,729,014 | ||||
| Total Medicare payment per Day at DRG | $2,196 | ||||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,193 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,513 | ||||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $8,497 | ||||
| Total Medicare Charges at DRG | $1,360,927,734 | ||||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $1,334,986,312 | ||||
| Avg Charges at DRG | $39,756 | ||||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $39,562 | ||||
| Mortality Rate at DRG | 0.08 | ||||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 0.08 | ||||
| SNF Discharge Rate at DRG | 4.73 | ||||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 4.76 | ||||
| Home Discharge Rate at DRG | 82.24 | ||||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 82.19 |
| DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 849: RADIOTHERAPY | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,355 | ||||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 1,342 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 2.36 | ||||
| Avg LOS at DRG | 3.15 | ||||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 3.16 | ||||
| Readmission Rate at DRG | 61.24 | ||||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 61.39 | ||||
| Unplanned Readmission Rate at DRG | 8.65 | ||||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 8.66 | ||||
| Total Medicare payments at DRG | $9,126,653 | ||||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $9,038,139 | ||||
| Total Medicare payment per Day at DRG | $2,135 | ||||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,132 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,736 | ||||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $6,735 | ||||
| Total Medicare Charges at DRG | $38,776,328 | ||||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $38,195,299 | ||||
| Avg Charges at DRG | $28,617 | ||||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $28,461 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 3.03 | ||||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 3.06 | ||||
| Home Discharge Rate at DRG | 87.97 | ||||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 88.0 |
| DRG 945: REHABILITATION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 826: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 602,372 | ||||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 165 | ||||
| DRG Share of Total Hospitalizations | 2.64 | ||||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 0.29 | ||||
| Avg LOS at DRG | 13.11 | ||||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 12.67 | ||||
| Readmission Rate at DRG | 15.99 | ||||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 27.21 | ||||
| Unplanned Readmission Rate at DRG | 12.22 | ||||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 21.32 | ||||
| Total Medicare payments at DRG | $11,047,686,856 | ||||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,768,987 | ||||
| Total Medicare payment per Day at DRG | $1,399 | ||||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $1,324 | ||||
| Total Medicare payment per Hospitalization at DRG | $18,340 | ||||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $16,782 | ||||
| Total Medicare Charges at DRG | $25,171,736,043 | ||||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $5,039,984 | ||||
| Avg Charges at DRG | $41,788 | ||||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $30,545 | ||||
| Mortality Rate at DRG | 0.21 | ||||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 17.37 | ||||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 11.52 | ||||
| Home Discharge Rate at DRG | 21.02 | ||||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 16.97 |
| DRG 827: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,859 | ||||
| Total Hospitalizations with ICD V5811 - Encounter for antineoplastic chemotherapy | 90 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD V5811 - Encounter for antineoplastic chemotherapy in DRG | 0.16 | ||||
| Avg LOS at DRG | 6.59 | ||||
| Avg LOS with ICD V5811 - Encounter for antineoplastic chemotherapy | 8.14 | ||||
| Readmission Rate at DRG | 19.99 | ||||
| Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 74.16 | ||||
| Unplanned Readmission Rate at DRG | 10.82 | ||||
| Unplanned Readmission Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 23.6 | ||||
| Total Medicare payments at DRG | $46,700,189 | ||||
| Total Medicare payments with ICD V5811 - Encounter for antineoplastic chemotherapy | $1,665,626 | ||||
| Total Medicare payment per Day at DRG | $2,477 | ||||
| Total Medicare payment per Day with ICD V5811 - Encounter for antineoplastic chemotherapy | $2,272 | ||||
| Total Medicare payment per Hospitalization at DRG | $16,334 | ||||
| Total Medicare payment per Hospitalization with ICD V5811 - Encounter for antineoplastic chemotherapy | $18,507 | ||||
| Total Medicare Charges at DRG | $223,869,991 | ||||
| Total Medicare Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $8,022,110 | ||||
| Avg Charges at DRG | $78,304 | ||||
| Avg Charges with ICD V5811 - Encounter for antineoplastic chemotherapy | $89,135 | ||||
| Mortality Rate at DRG | 0.7 | ||||
| Mortality Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 8.99 | ||||
| SNF Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 13.33 | ||||
| Home Discharge Rate at DRG | 63.52 | ||||
| Home Discharge Rate with ICD V5811 - Encounter for antineoplastic chemotherapy | 64.44 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2013 to Dec 2014 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 2,377 |
| THE UNIVERSITY OF CHICAGO MEDICAL CENTER | 5841 S. MARYLAND AVE | CHICAGO | IL | 60637 | 751 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 572 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2013 to Dec 2014 ) |
|---|---|---|---|---|---|
| Dr. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 223 |
| Dr. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 184 |
| Dr. ARLENE O. SIEFKER-RADTKE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 162 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Jan 2013 to Dec 2014 ) |
|---|---|---|---|---|---|
| Dr. TAMARA LEA MUSGRAVE | 172 S MAYO TRL | PIKEVILLE | KY | 41501 | 231 |
| Dr. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 187 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 132 |